| |
|
Form Serial Number: |
CS20260615E00323 |
| 1.
Date of relevant event: |
11/06/2026
(dd/mm/yyyy)
|
| 2.
Date when the substantial shareholder becomes aware of the relevant event / interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06086 |
| 4.
Name of listed corporation: |
Fangzhou Inc. |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
1,385,448,457 |
| 7.
Name of substantial shareholder: |
Crescent Capital Investments Ltd. |
| 8.
Registered office: |
Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands |
| 9.
Principal place of business in Hong Kong: |
N/A |
| 15.
Exchange on which listed: |
N/A |
| 16.
Name of listed parent and exchange on which parent is listed: |
Ares Management Corporation (New York Stock Exchange) |
|
| 17.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved |
Currency of transaction |
On Exchange
|
Off Exchange
|
| Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Nature of consideration
|
|
Long position |
| 1001 | You first acquire a notifiable interest because:
you purchased the shares |
|
|
| 2201 | Interest of corporation controlled by you |
|
322,278,770 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
|
|
| 18.
Total shares immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 0 | 0.00 |
|
|
| 19.
Total shares immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 322,278,770 | 23.26 |
|
|
| 20.
Capacity in which interests disclosed in Box 19 are held: |
| Capacity code | Number of shares |
| 2201 | Interest of corporation controlled by you |
| |
|
|
|
|
| 21.
Further information in respect of derivative interests: |
| Derivatives code | Number of shares |
| | |
|
|
| 22.
Further information in relation to interests of corporations controlled by substantial shareholder: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| AP eTech Holdings Ltd | Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands) | Crescent Capital Investments Ltd. | 100.00 | N | |
| AP eTech Investments Ltd | Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands) | AP eTech Holdings Ltd | 100.00 | N | |
| Asia Pac e-Commerce Opportunities Pte. Ltd. | 77 Robinson Road, #13-00, Robinson 77, Singapore 068896 (Singapore) | AP eTech Investments Ltd | 100.00 | Y | |
| PharmaTech Holdings II Ltd | Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands) | Crescent Capital Investments Ltd. | 100.00 | N | |
| Tech-Med Holdings III Ltd | Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands) | Crescent Capital Investments Ltd. | 100.00 | N | |
| PharmaTech Investments II Ltd | Walkers Corporate Limited, 190 Elgin Avenue, George Town, Grand Cayman KY1-9008, Cayman Islands (Cayman Islands) | PharmaTech Holdings II Ltd | 84.51 | N | |
| Tech-Med Cayman III Ltd. | Intertrust Corporate Services (Cayman) Limited, One Nexus Way, Camana Bay, Grand Cayman KY1-9005, Cayman Islands (Cayman Islands) | Tech-Med Holdings III Ltd | 100.00 | N | |
| Tech-Med Investments (S) Pte. Ltd. | 261 Waterloo Street, #02-30, Waterloo Centre, Singapore 180261 (Singapore) | Tech-Med Cayman III Ltd. | 100.00 | Y | |
| CP PharmaTech Singapore Pte. Ltd. | 261 Waterloo Street, #02-30, Waterloo Centre, Singapore 180261 (Singapore) | PharmaTech Investments II Ltd | 100.00 | Y | |
|
|
|
| 23.
Further information in relation to interests held by substantial shareholder jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
|
| 24.
Further information from a trustee, a beneficiary of a trust, or a person who set up a discretionary trust: |
| Names of trust | Address | Status code | Number of shares |
| | | |
|
|
| 25.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a substantial shareholder is interested under sections 317 and 318 | |
|
|
| 26.
Details of person(s) in accordance with whose directions the substantial shareholder or its directors are accustomed to act: |
| Names | Address | Relationship Code | Percentage (%) |
| | | |
|
| |
| 27.
Supplementary information: |
Effective from 10 June 2026, Tech-Med Investments (S) Pte. Ltd. appointed Mr. Zhou Feng, an executive director of Fangzhou Inc., jointly as its attorney and proxy to exercise the voting rights in respect of 54,000,000 ordinary shares of Fangzhou Inc. held by Tech-Med Investments (S) Pte. Ltd.
|
| 28.
Log/Serial Number of the previous form: |
|
| 29.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 2: |
15/06/2026
(dd/mm/yyyy)
|
|
|
|
|